Livermore
Earnings callsUse CasesNewsDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Livermore

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GRFS

Grifols SA

CIK 0001438569 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$7.69
↓ 0.13 (-1.66%)
as of Aug 28, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Options

Key stats

Market Cap
$1.99B
P/E Ratio
Not covered
EPS
0.23
Dividend Yield
Not covered
52W Position
22%
Beta
0.88

Valuation multiples

Fwd P/E
8.48
PEG
0.23
P/B
Not covered
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,744/9,719 US-listed stocks (90.0%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 22%
$6.96$10.23

Latest Financials

2024-12-31 FY
Revenue
$7.21B
Net Income
$212.81M
Total Assets
$21.41B
Free Cash Flow
$669.63M

Recent news